Analysis of the Clinical Effects of Different Emergency Thrombolytic Drugs in the Treatment of Acute Myocardial Infarction
Objective To observe the effect of different emergency thrombolytic drugs in the clinical treatment of acute myocardial infarction.Methods A total of 70 patients with acute myocardial infarction admitted to Shanxian Central Hospital from March 2021 to November 2023 were selected as the study objects and divided into two groups according to random number table method,with 35 patients in each group.The control group was treated with uroki-nase,and the observation group was treated with recombinant pro-urokinase(rhPro-UK).The cardiac function in-dexes,incidence of adverse reactions and clinical efficacy of the two groups were compared.Results After treatment,left ventricular end-diastolic diameter(34.55±3.25)mm,left ventricular ejection fraction(67.02±3.56)%,6-min test(660.21±70.45)m,B-type natriuretic peptide(80.34±5.23)ng/L in the observation group were better than those in the control group,and the differences were statistically significant(t=33.814,34.054,18.921,22.802,all P<0.05).The clinical efficacy of the observation group was better than that of the control group,and the incidence of adverse reac-tions was lower than that of the control group,and the differences were statistically significant(both P<0.05).Conclu-sion Patients with acute myocardial infarction were treated well with rhPro-UK,which could significantly improve their quality of life.
万方数据
维普
